ERBB2 and neoplasm: To explorethe activation of SQP22 in vivo without tumor injections,we developed a human epidermal growth factor receptor 2 (HER2) antigen-bindingfragment (Fab) conjugated to tetrazine and designated it as SQT01(Figure 1D).